LTR Pharma

🔹 New agreement 🔹 LTR Pharma is pleased to announce it has entered into an access agreement with Men's Health Downunder (MHDU) to facilitate access to SPONTAN® through the TGA’s Special Access Scheme. MHDU is a specialised men's health provider, operating a multidisciplinary network of healthcare professionals across multiple locations. The partnership is already showing results, with MHDU having dispensed SPONTAN® to its first patient under the agreement. The agreement leverages MHDU's established network of specially trained pharmacists and comprehensive men's health services across multiple locations in Australia. MHDU's clinics currently service over 1,000 patients annually through specialist urological health support services. The agreement provides LTR Pharma access to MHDU's extensive referral network, including general practitioners, urologists, and sexual health clinics. This partnership aligns with the Company's strategy to introduce SPONTAN through trusted healthcare providers while gathering valuable real-world patient data. LTR Pharma Chairman, Lee Rodne said: "The agreement with Men's Health Downunder represents another significant milestone in SPONTAN's commercialisation journey. By partnering with Australia's largest men's health pharmacy clinic, we continue to broaden access to SPONTAN while maintaining our commitment to patient care through qualified healthcare professionals."   Read the ASX Release 👉 https://bit.ly/LTP-MHDU   $LTP #LTRPharma #menshealth #erectiledysfunction #nasalspray #healthcare #innovation

💻 Telehealth Platform Now Live LTR Pharma's joint venture partner Restorative Health Clinic has today launched its online men's health platform ahead of schedule, delivering comprehensive telehealth services to Australian men. The platform combines clinical expertise in men's health with access to innovative treatments, including SPONTAN®, providing Australian men with convenient access to healthcare professionals and evidence-based treatments. Australian men can now book consultations via rshealth.com.au. LTR Pharma Executive Chairman, Lee Rodne, said: “This early launch by our joint venture partner demonstrates strong market demand for innovative healthcare solutions in men’s health. The platform provides an additional channel for delivering treatments, including SPONTAN, to Australian men via early access scheme pathways. We look forward to working with the RHC team to support the delivery of professional healthcare services in this growing online market." Read today's ASX release 👉 https://lnkd.in/g9dMPVnz $LTP #ASX #menshealth #healthcare #telehealth #innovation Melissa Hadley Barrett

💰 CAPITAL RAISE   LTR Pharma has today announced it has successfully completed a A$25 million placement to institutional and sophisticated investors to accelerate SPONTAN®’s commercialistion. These funds will accelerate the Company’s progress in the U.S.; increase R&D investment for product portfolio expansion and manufacturing scale-up; and assist with launching an innovative telehealth platform to create a seamless experience for healthcare providers and patients alike. LTR Pharma Chairman, Lee Rodne, commented: "This funding is a critical milestone for LTR Pharma as we advance towards commercialising SPONTAN® in the US, Australia and other key markets. With our preparations for regulatory engagement underway, and with our strategic partnerships, including our co-development agreement with Aptar Pharma, we are well-positioned to bring a first-in-class, rapid-onset treatment to market.   "This marks the beginning of the next transformative chapter for LTR Pharma as we look ahead to the commercialisation of SPONTAN® and pioneering innovations in nasal spray therapeutics." See today’s ASX release 👉 https://lnkd.in/gB_SrXhW   $LTP #LTRPharma #erectiledysfunction #menshealth #innovation #healthcare 

📺 Conversation Series | Mental Health & ED with Dr. Tom Silva In this latest video from our Conversation Series, specialist GP Dr. Tom Silva discusses the critical intersection of mental health and erectile dysfunction. Dr. Silva shares valuable insights on how anxiety cycles can impact treatment success, and the importance of addressing both psychological and physical aspects of ED in general practice. He emphasises how modern treatment options can help reduce treatment-related anxiety and improve patient outcomes. Take a look 👉 https://lnkd.in/gq4v5wVq $LTP #LTRPharma #erectiledysfunction #menshealth #mentalhealth #healthcare #innovation Thomaz De Campos Silva

📺 Treatments for ED | Dr Tom Silva Check out the third video from our Conversation Series with Dr Thomaz De Campos Silva Dr Silva is a specialist GP and University of Queensland lecturer with unique expertise in erectile dysfunction treatments, including experience with complex post-prostate cancer cases. In this video, Dr Silva provides a comprehensive overview of current ED medications and their mechanisms of action, particularly focusing on PDE5 inhibitors.  Drawing from his clinical experience, Dr Silva discusses the practical challenges patients face with existing treatments, and how quick-onset options like SPONTAN® are addressing these long-standing challenges. Take a look 👉 https://lnkd.in/gzm5CvAp $LTP #LTRPharma #menshealth #erectiledysfunction #innovation #pharma #nasalspray

📺 ED Discussions in Primary Care | Dr Tom Silva The second video from our Conversation Series with Dr Tom Silva is now live. Dr Silva is a specialist GP and University of Queensland lecturer with unique expertise in erectile dysfunction treatments, including experience with complex post-prostate cancer cases. In this conversation, Dr Silva shares his clinical experience with SPONTAN®, discussing how the innovative nasal spray is creating new possibilities for ED treatment. He highlights the medication's effectiveness in patients who haven't responded well to other treatments, and how the right treatment in a comfortable general practice environment can help break the cycle of anxiety that many patients experience. Take a look 👉 https://lnkd.in/gki5v3nP $LTP #LTRPharma #menshealth #erectiledysfunction #innovation #pharma #nasalspray

🎙️ Podcast Interview LTR Pharma Executive Chairman, Lee Rodne, featured on the Red Leaf Securities Pty Ltd podcast this week, in conversation with host John Athanasiou. In the interview, Lee discusses SPONTAN, the Company’s innovative nasal spray for the treatment of Erectile Dysfunction (ED), and how their patented technology is addressing a significant unmet medical need affecting millions globally. Reflecting on the market opportunity, Lee commented: “The US market alone represents 30 million men with erectile dysfunction. If we take just one of 10 men, that’s a $400 million revenue opportunity – and that’s just the US.” Have a listen: https://lnkd.in/gUg3wMxA $LTP #LTRPharma #biotech #pharma #innovation #menshealth #erectiledysfunction #invest

📰 STOCKHEAD LTR Pharma's plans to launch a new men’s online healthcare platform in partnership with the Restorative Sexual Health Clinic (RSHC) has been featured in a special report on Stockhead. The platform aims to meet the growing demand for accessible healthcare solutions, and will offer a convenient channel for men to access professional healthcare services and prescribed treatments. Take a look 👉 https://lnkd.in/gXF3nK2G $LTP #LTRPharma #menshealth #telehealth #healthcare #erectiledysfunction #innovation

LTR Pharma (ASX: LTP) is pleased to share that it has recently been included in the MSCI Australia Index. The MSCI serves as an important barometer of the Australian equity market and is particularly relevant for international investors looking to track or invest in the Australian market. This inclusion reflects LTR Pharma’s growing market presence and increases the Company’s visibility to institutional investors globally. $LTP #LTRPharma #invest #menshealth

📰 In The News LTR Pharma's exciting new joint venture with Restorative Sexual Health Clinic (RSHC) to launch an online healthcare platform dedicated to men’s health has been featured in The Medical Republic. Here's an excerpt: '𝘔𝘦𝘭𝘪𝘴𝘴𝘢 𝘏𝘢𝘥𝘭𝘦𝘺 𝘉𝘢𝘳𝘳𝘦𝘵𝘵, 𝘧𝘰𝘶𝘯𝘥𝘦𝘳 𝘰𝘧 𝘵𝘩𝘦 𝘙𝘚𝘏𝘊 𝘴𝘢𝘪𝘥: “𝘛𝘩𝘪𝘴 𝘱𝘢𝘳𝘵𝘯𝘦𝘳𝘴𝘩𝘪𝘱 𝘢𝘭𝘪𝘨𝘯𝘴 𝘱𝘦𝘳𝘧𝘦𝘤𝘵𝘭𝘺 𝘸𝘪𝘵𝘩 𝘰𝘶𝘳 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘵𝘰 𝘱𝘳𝘰𝘷𝘪𝘥𝘦 𝘤𝘰𝘮𝘱𝘳𝘦𝘩𝘦𝘯𝘴𝘪𝘷𝘦, 𝘦𝘷𝘪𝘥𝘦𝘯𝘤𝘦-𝘣𝘢𝘴𝘦𝘥 𝘤𝘢𝘳𝘦 𝘵𝘩𝘢𝘵 𝘦𝘯𝘩𝘢𝘯𝘤𝘦𝘴 𝘮𝘦𝘯’𝘴 𝘸𝘦𝘭𝘭-𝘣𝘦𝘪𝘯𝘨.   “𝘛𝘩𝘦 𝘰𝘯𝘭𝘪𝘯𝘦 𝘱𝘭𝘢𝘵𝘧𝘰𝘳𝘮 𝘸𝘪𝘭𝘭 𝘦𝘹𝘱𝘢𝘯𝘥 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘰 𝘰𝘶𝘳 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭 𝘴𝘦𝘳𝘷𝘪𝘤𝘦𝘴 𝘸𝘩𝘪𝘭𝘦 𝘮𝘢𝘪𝘯𝘵𝘢𝘪𝘯𝘪𝘯𝘨 𝘵𝘩𝘦 𝘩𝘪𝘨𝘩 𝘴𝘵𝘢𝘯𝘥𝘢𝘳𝘥𝘴 𝘰𝘧 𝘤𝘢𝘳𝘦 𝘵𝘩𝘢𝘵 𝘥𝘦𝘧𝘪𝘯𝘦 𝘰𝘶𝘳 𝘧𝘢𝘤𝘦-𝘵𝘰-𝘧𝘢𝘤𝘦 𝘤𝘭𝘪𝘯𝘪𝘤."   Take a look 👉 https://lnkd.in/gzT7DN59 $LTP #LTRPharma #menshealth #erectiledysfunction #innovation #nasalspray #telehealth